Literature DB >> 15348536

Indirect cytotoxicity evaluation of pseudowollastonite.

D Dufrane1, C Delloye, I J McKay, P N De Aza, S De Aza, Y J Schneider, M Anseau.   

Abstract

This study aimed to evaluate the cytotoxicity of substances leached by pseudowollastonite (CaSiO(3)). It has been previously shown that calcium (Ca(2+)) and silicate (SiO(3)(-)) ions are released from pseudowollastonite into biological solutions. Both of these ions are known to influence the biological metabolism of osteoblastic cells essential in the mineralization process and bone-bonding mechanism. The indirect toxicity evaluation was performed by extraction method, according to International Standard Organization (ISO). Pseudowollastonite pellets obtained by solid-state reaction were incubated, in culture medium, during 24, 48, 72 or 168 h at different concentrations (5, 10, 15, 50, 100, 200 mg/ml). The cytotoxicity of each extract in presence of human osteoblastic cell line (SaOS-2) was quantitatively assessed by measuring the viability (succinate dehydrogenase activity, MTT), the membrane integrity (the uptake of the neutral red by viable cells, NR) as well as the cell necrosis by measuring the lactate dehydrogenase (LDH) released in the culture medium. No significant alteration of membrane integrity or cell suffering was detectable. However, increased cell metabolism was observed for cells exposed to pseudowollastonite extract with longest extraction time (168 h). In conclusion, mineral elements leached by pseudowollastonite do not significantly affect the metabolism of osteoblastic cells.

Entities:  

Year:  2003        PMID: 15348536     DOI: 10.1023/a:1021545302732

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  23 in total

Review 1.  Current trends in biocompatibility testing.

Authors:  C J Kirkpatrick; F Bittinger; M Wagner; H Köhler; T G van Kooten; C L Klein; M Otto
Journal:  Proc Inst Mech Eng H       Date:  1998       Impact factor: 1.617

2.  Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties.

Authors:  S B Rodan; Y Imai; M A Thiede; G Wesolowski; D Thompson; Z Bar-Shavit; S Shull; K Mann; G A Rodan
Journal:  Cancer Res       Date:  1987-09-15       Impact factor: 12.701

3.  Characterization of nodules induced by bioactive glass on cultured periodontal-ligament fibroblasts.

Authors:  K Kubo; T Kamada; T Matsuyama; N Tsukasa; M Uehara; Y Izumi; M Kitano; M Ogino; T Sueda
Journal:  J Biomed Mater Res       Date:  1995-04

4.  Biocompatibility test procedures for materials evaluation in vitro. II. Objective methods of toxicity assessment.

Authors:  H J Johnson; S J Northup; P A Seagraves; M Atallah; P J Garvin; L Lin; T D Darby
Journal:  J Biomed Mater Res       Date:  1985 May-Jun

5.  Quantitative in vitro assessment of phototoxicity by a fibroblast-neutral red assay.

Authors:  R M Lasarow; R R Isseroff; E C Gomez
Journal:  J Invest Dermatol       Date:  1992-05       Impact factor: 8.551

6.  The biocompatibility of hydroxyapatite ceramic: a study of retrieved human middle ear implants.

Authors:  C A van Blitterswijk; S C Hesseling; J J Grote; H K Koerten; K de Groot
Journal:  J Biomed Mater Res       Date:  1990-04

7.  Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production.

Authors:  D T Vistica; P Skehan; D Scudiero; A Monks; A Pittman; M R Boyd
Journal:  Cancer Res       Date:  1991-05-15       Impact factor: 12.701

8.  In vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium laurylsulfate cytotoxicity.

Authors:  C Verhulst; C Coiffard; L J Coiffard; P Rivalland; Y De Roeck-Holtzhauer
Journal:  J Pharmacol Toxicol Methods       Date:  1998-04       Impact factor: 1.950

9.  High-resolution and analytical electron microscopic studies of new crystals induced by a bioactive ceramic (diopside).

Authors:  Y Miake; T Yanagisawa; Y Yajima; H Noma; N Yasui; T Nonami
Journal:  J Dent Res       Date:  1995-11       Impact factor: 6.116

10.  Matrix deposition by a calcifying human osteogenic sarcoma cell line (SAOS-2).

Authors:  D J McQuillan; M D Richardson; J F Bateman
Journal:  Bone       Date:  1995-04       Impact factor: 4.398

View more
  6 in total

1.  Influence of thermal treatment on the "in vitro" bioactivity of wollastonite materials.

Authors:  Miguel A de la Casa-Lillo; Pablo Velásquez; Piedad N De Aza
Journal:  J Mater Sci Mater Med       Date:  2011-02-19       Impact factor: 3.896

2.  Human tissue allograft processing: impact on in vitro and in vivo biocompatibility.

Authors:  S Fawzi-Grancher; R M Goebbels; E Bigare; O Cornu; P Gianello; C Delloye; D Dufrane
Journal:  J Mater Sci Mater Med       Date:  2009-03-20       Impact factor: 3.896

3.  Silver-doped bioactive glass particles for in vivo bone tissue regeneration and enhanced methicillin-resistant Staphylococcus aureus (MRSA) inhibition.

Authors:  Natalia Pajares-Chamorro; Yadav Wagley; Chima V Maduka; Daniel W Youngstrom; Alyssa Yeger; Stephen F Badylak; Neal D Hammer; Kurt Hankenson; Xanthippi Chatzistavrou
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2020-11-05       Impact factor: 7.328

4.  Calcium silicate as a graft material for bone fractures: a systematic review.

Authors:  Marcelo Sanmartin de Almeida; Gustavo Vicentis de Oliveira Fernandes; Aline Muniz de Oliveira; José Mauro Granjeiro
Journal:  J Int Med Res       Date:  2018-05-30       Impact factor: 1.671

5.  Nanosized mesoporous bioactive glass/poly(lactic-co-glycolic acid) composite-coated CaSiO3 scaffolds with multifunctional properties for bone tissue engineering.

Authors:  Mengchao Shi; Dong Zhai; Lang Zhao; Chengtie Wu; Jiang Chang
Journal:  Biomed Res Int       Date:  2014-03-02       Impact factor: 3.411

6.  Screening of Cytotoxic B. cereus on Differentiated Caco-2 Cells and in Co-Culture with Mucus-Secreting (HT29-MTX) Cells.

Authors:  Virginie Castiaux; Laurie Laloux; Yves-Jacques Schneider; Jacques Mahillon
Journal:  Toxins (Basel)       Date:  2016-11-05       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.